Postmenopausal hypertension: Role of the sympathetic nervous system in an animal model

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 4, 2014, Pages

  Maranon, Rodrigo O ^a,b   Lima, Roberta ^a,b   Mathbout, Mohammed ^c   do Carmo, Jussara M ^b   Hall, John E ^b   Roman, Richard J ^a,b   Reckelhoff, Jane F ^a,b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Aging; Leptin; Melanocortin 3 4 receptor; Renal denervation; Sex differences

Indexed keywords

AGING; LEPTIN; MELANOCORTIN 3/4 RECEPTOR; RENAL DENERVATION; SEX DIFFERENCES;

AGE FACTORS; ANIMALS; BLOOD PRESSURE; DENERVATION; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION; KIDNEY; LEPTIN; MELANOCYTE-STIMULATING HORMONES; POSTMENOPAUSE; RATS; RATS, INBRED SHR; RECEPTOR, MELANOCORTIN, TYPE 2; RECEPTOR, MELANOCORTIN, TYPE 3; SYMPATHETIC NERVOUS SYSTEM;

EID: 84894075204     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00490.2013     Document Type: Article

References (42)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 14: 177-183, 1989.
2. Bucher B, Heitz C, Stoclet JC. Age-related changes of in vivo betaadrenergic responsiveness in normotensive an spontaneously hypertensive rats. Eur J Pharmacol 102: 31-37, 1984.
3. Chen WQ, Cai H, Zhang C, Ji XP, Zhang Y. Is overall blockade superior to selective blockade of adrenergic receptor subtypes in suppressing left ventricular remodeling in spontaneously hypertensive rats? Hypertens Res 33: 1071-1081, 2010.
4. Chowen-Breed J, Fraser HM, Vician L, Damassa DA, Clifton DK, Steiner RA. Testosterone regulation of proopiomelanocortin messenger ribonucleic acid in the arcuate nucleus of the male rat. Endocrinology 124: 1697-702, 1989.
5. Coote JH, Sato Y. Reflex regulation of sympathetic activity in the spontaneously hypertensive rat. Circ Res 40: 571-577, 1977.
6. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52: 818-827, 2008.
7. Czarnecka D, Posnik-Urbanska A, Kawecka-Jaszcz K, Kolasinska-Klock W, Wojciechowska W, Redak D. Indices of autonomic nervous system activity in women with mild hypertension in the perimenopausal period. Kardiol Pol 67: 243-251, 2009.
8. da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension 51: 884-890, 2008.
9. DiBona GF. Sympathetic nervous system and hypertension. Hypertension 61: 556-560, 2013.
10. do Carmo JM, da Silva AA, Dubinion J, Sessums PO, Ebaady SH, Wang Z, Hall JE. Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB Life 65: 692-698, 2013.
11. Engberding N, Wenger NK. Management of hypertension in women. Hypertens Res 35: 251-60, 2012.
12. Esler M, Rumantir M, Wiesner G, Kaye D, Hastings J, Lambert G. Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 14: 304S-309S, 2001.
13. Gruenewald DA, Matsumoto AM. Age-related decrease in proopiomelanocortin gene expression in the arcuate nucleus of the male rat brain. Neurobiol Aging 12: 113-121, 1991.
14. Hall JE, Da Silva AA, do Carmo JM, Dubinioon J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 285: 17271-17276, 2010.
15. Hart EC, Charkoudian N, Wallin BG, Curry TB, Eisenach JH, Joyner MJ. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 53: 571-576, 2009.
16. Hogarth AJ, Graham LN, Corrigan JH, Deuchars J, Mary DA, Greenwood JP. Sympathetic nerve hyperactivity and its effect in postmenopausal women. J Hypertens 29: 2167-2175, 2011.
17. Iliescu R, Yanes LL, Bell W, Dwyer T, Baltatu OC, Reckelhoff JF. Role of the renal nerves in blood pressure in male and female SHR. Am J Physiol Regul Integr Comp Physiol 290: R341-R344, 2006.
18. Kim JK, Alley D, Seeman T, Karlamangla A, Crimmins E. Recent changes in cardiovascular risk factors among women and men. J Womens Health 15: 734-746, 2006.
19. Lansdown A, Rees DA. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target? Clin Endocrinol (Oxf) 77: 791-801, 2012.
20. Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep 14: 254-60, 2012.
21. Lima R, Yanes LL, Davis DD, Reckelhoff JF. Roles played by 20-HETE, angiotensin II and endothelin in mediating the hypertension in aging female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 304: R248-R251, 2013.
22. Ma D, Feitosa MF, Wilk JB, Laramie JM, Yu K, Leiendecker-Foster C, Myers RH, Province MA, Borecki IB. Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung and Blood Institute Family Heart Study. Hypertension 53: 473-479, 2009.
23. Maranon R, Reckelhoff JF. Sex and gender differences in control of blood pressure. Clin Sci (Lond) 125: 311-318, 2013.
24. Mestivier D, Dabire H, Chau NP. Effects of autonomic blockers on linear and nonlinear indexes of blood pressure and heart rate in SHR. Am J Physiol Heart Circ Physiol 281: H1113-H1121, 2001.
25. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45: 522-525, 2005.
26. Ng AV, Callister R, Johnson DG, Seals DR. Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension 21: 498-503, 1993.
27. Reckelhoff JF, Wofford M. Hypertension in women. In: Women and Health (2nd ed.), edited by Rexrode K, Wickline M. New York: Elsevier, chapt. 70, 2012.
28. Saragoca M, Tarazi RC. Impaired cardiac contractile response to isoproterenol in the spontaneously hypertensive rat. Hypertension 3: 380-385, 1981.
29. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 29: 991-996, 2011.
30. Schlaich MP, Krum H, Esler MD. New therapeutic approaches to resistant hypertension. Curr Hypertens Rep 12: 296-302, 2010.
31. Seals DR, Esler MD. Human ageing and the sympathoadrenal system. J Physiol 528: 407-417, 2000.
32. Symplicity HTN1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57: 911-917, 2011.
33. Tank J, Heusser K, Doedrich A, Hering D, Luft FC, Busjahn A, Narkiewic K, Jordan J. Infuences of gender on the interaction between sympathetic nerve traffic and central adiposity. J Clin Endocrinol Metab 93: 4974-4978, 2008.
34. Vianna LC, Hart EC, Fairfax ST, Charkoudian N, Joyner MJ, Fadel PJ. Influence of age and sex on the pressor response following a spontaneous burst of muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 302: H2419-H2427, 2012.
35. Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 41: 1358-1363, 2003.
36. Weitz G, Elam M, Born J, Fehm HL, Dodt C. Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 86: 344-348, 2001.
37. Xue B, Zhang Z, Beltz TG, Johnson RF, Gou F, Hay M, Johnson AK. Estrogen receptor-γ in the paraventricular nucleous and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats. Hypertension 61: 1255-1262, 2013.
38. Yanes LL, Romero D, Cucchiarelli VE, Fortepiani LA Gomez-Sanchez CE, Santacruz F, Reckelhoff JF. Role of endothelin in a model of postmenopausal hypertension. Am J Physiol Regul Integr Comp Physiol 288: R229-R233, 2005.
39. Yanes LL, Romero DG, Iles JW, Iliescu R, Gomez-Sanchez CE, Reckelhoff JF. Sexual dimorphism in the renin-angiotensin system in aging spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 291: R383-R390, 2006.
40. Yanes Lima R LL, Romero DG, Moulana M, Yuan K, Zhang Ryan MJ Reckelhoff JFH. Postmenopausal hypertension: role of HETE. Am J Physiol Regul Integr Comp Physiol 300: R1543-R1548, 2011.
41. Yanes LL, Reckelhoff JF. Postmenopausal hypertension. Am J Hypertens 24: 740-749, 2011.
42. Yoshida M, Yoshida E, Satoh S. Effect of renal nerve denervation on tissue catecholamine content in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22: 512-517, 1995.